Hyperkalemia in heart failure: Probably not O"K"

Marat Fudim; Justin L. Grodin; Robert J. Mentz

doi:10.1161/JAHA.118.009429

Hyperkalemia in heart failure: Probably not O"K"

Marat Fudim, Justin L. Grodin, Robert J. Mentz

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	e009429
Journal	Journal of the American Heart Association
Volume	7
Issue number	11
DOIs	https://doi.org/10.1161/JAHA.118.009429
State	Published - Jun 1 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1161/JAHA.118.009429

Cite this

@article{d41bded9c7bd49208e44c6a341e171e7,

title = "Hyperkalemia in heart failure: Probably not O{"}K{"}",

author = "Marat Fudim and Grodin, {Justin L.} and Mentz, {Robert J.}",

note = "Funding Information: Fudim is supported by American Heart Association grant 17MCPRP33460225 and the National Heart, Lung, and Blood Institute T32 postdoctoral training grant 5T32HL007101-42, and reports consulting for Coridea, AxonTherapies, and Galvani. Mentz receives research support from the National Institutes of Health (U01HL125511-01A1, U10HL110312, and R01AG045551-01A1), Amgen, AstraZeneca, Bayer, GlaxoSmithKline, Gilead, Luitpold, Medtronic, Merck, Novartis, Otsuka, and ResMed; reports honoraria from Abbott, Bayer,",

year = "2018",

month = jun,

day = "1",

doi = "10.1161/JAHA.118.009429",

language = "English (US)",

volume = "7",

journal = "Journal of the American Heart Association",

issn = "2047-9980",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Hyperkalemia in heart failure

T2 - Probably not O"K"

AU - Fudim, Marat

AU - Grodin, Justin L.

AU - Mentz, Robert J.

N1 - Funding Information: Fudim is supported by American Heart Association grant 17MCPRP33460225 and the National Heart, Lung, and Blood Institute T32 postdoctoral training grant 5T32HL007101-42, and reports consulting for Coridea, AxonTherapies, and Galvani. Mentz receives research support from the National Institutes of Health (U01HL125511-01A1, U10HL110312, and R01AG045551-01A1), Amgen, AstraZeneca, Bayer, GlaxoSmithKline, Gilead, Luitpold, Medtronic, Merck, Novartis, Otsuka, and ResMed; reports honoraria from Abbott, Bayer,

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85048010193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048010193&partnerID=8YFLogxK

U2 - 10.1161/JAHA.118.009429

DO - 10.1161/JAHA.118.009429

M3 - Editorial

C2 - 29789333

AN - SCOPUS:85048010193

SN - 2047-9980

VL - 7

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

IS - 11

M1 - e009429

ER -

Hyperkalemia in heart failure: Probably not O"K"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this